These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12647994)

  • 1. Biomarkers in melanoma: predisposition, screening and diagnosis.
    Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS
    Expert Rev Mol Diagn; 2003 Mar; 3(2):163-84. PubMed ID: 12647994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnostics in melanoma.
    Carlson JA; Ross JS; Slominski A; Linette G; Mysliborski J; Hill J; Mihm M
    J Am Acad Dermatol; 2005 May; 52(5):743-75; quiz 775-8. PubMed ID: 15858465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers in melanoma: staging, prognosis and detection of early metastases.
    Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS
    Expert Rev Mol Diagn; 2003 May; 3(3):303-30. PubMed ID: 12779006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging.
    Carlson JA; Slominski A; Linette GP; Mysliborski J; Hill J; Mihm MC; Ross JS
    Am J Clin Pathol; 2003 Dec; 120 Suppl():S101-27. PubMed ID: 15298147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of biomarkers for melanoma metastasis.
    Sondak VK; Messina JL
    IDrugs; 2006 Sep; 9(9):627-31. PubMed ID: 16952070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous melanoma: update on prevention, screening, diagnosis, and treatment.
    Rager EL; Bridgeford EP; Ollila DW
    Am Fam Physician; 2005 Jul; 72(2):269-76. PubMed ID: 16050450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous melanoma: public health approach to early detection.
    Weinstock MA
    Dermatol Ther; 2006; 19(1):26-31. PubMed ID: 16405567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas.
    Fröhlich E; Mack AF; Garbe C; Klessen C
    Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of familial melanoma and nonmelanoma skin cancer syndromes.
    Santillan AA; Cherpelis BS; Glass LF; Sondak VK
    Surg Oncol Clin N Am; 2009 Jan; 18(1):73-98, viii. PubMed ID: 19056043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: a report of 47 cases.
    Manganoni AM; Farisoglio C; Tucci G; Facchetti F; Calzavara Pinton PG
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1333-6. PubMed ID: 17958838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma.
    Pho L; Grossman D; Leachman SA
    Curr Opin Oncol; 2006 Mar; 18(2):173-9. PubMed ID: 16462187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
    Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The control of melanoma in New Zealand.
    Sneyd M; Cox B
    N Z Med J; 2006 Sep; 119(1242):U2169. PubMed ID: 16998570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for cutaneous melanoma.
    Lange JR; Balch CM
    Surg Oncol Clin N Am; 2005 Oct; 14(4):799-811. PubMed ID: 16226692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemistry in melanocytic proliferative lesions.
    de Wit NJ; van Muijen GN; Ruiter DJ
    Histopathology; 2004 Jun; 44(6):517-41. PubMed ID: 15186267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiology and prevention of melanoma].
    Grob JJ; Richard MA
    Rev Prat; 2004 Jun; 54(11):1181-6. PubMed ID: 15496024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
    Fisher NM; Schaffer JV; Berwick M; Bolognia JL
    J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant melanoma -- a medical students' viewpoint].
    Felcht M; Fischer JC; Michels M; Weinhold M; Zouboulis CC
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):421-30. PubMed ID: 15892844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients.
    Geller AC; Emmons KM; Brooks DR; Powers C; Zhang Z; Koh HK; Heeren T; Sober AJ; Li F; Gilchrest BA
    Cancer; 2006 Aug; 107(4):806-14. PubMed ID: 16832795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.